Two viruses can attack the same organ, yet the way they spread and the damage they cause are remarkably different. While ...

October 20 is Liver Day, designated by the Korean Liver Foundation and the Korean Association for the Study of the Liver.

The findings run counter to updated guidance issued in January 2025 by the U.S. Centers for Disease Control and Prevention ...

The approval of Hibsago has created a new market for a handful of biopharmas, including Gilead, Arrowhead, and Vir, to fill ...

Ending routine vaccination for hepatitis B at birth, as the health secretary has recommended, would increase the number of ...

The Delhi Government plans to strengthen the diagnosis and management of Hepatitis B and Hepatitis C by utilising existing ...

Dr. Norah Terrault, Chief of Gastroenterology & Hepatology, USC Keck Medical Center, said: “This is the start of a new era in treating people living with CHB. Bepirovirsen offers patients the ...

CHB affects approximately 1.7 million people in the US 1. GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Hibsago (bepirovirsen ...

A recent study published in the 'Annals of Internal Medicine' projected that hepatitis B infections could increase by at ...

US Approves GSK's Hibsago - Washington, D.C. – The United States has given its nod to a new treatment for chronic hepatitis B ...

Almost 4% of the participants who experienced a seizure reported exposure to high-level blasts, while fewer than 2% reported ...

Approval based on Phase 3 data showing unprecedented functional cure rates compared to standard of care – – Six-month ...